Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about BIIB

Recent news which mentions BIIB

< Previous 1 2
...
22 23 24 25 26 27 28 29 30
...
32 33 Next >
Things Just Got Worse for Biogen
Tickers BIIB
Tags Recent Press Releases BIIB Market News
From Motley Fool
Is This Biotech Stock Worth the Trouble?
Tickers BIIB ESALY LLY SAGE
Tags LLY BIIB SAGE
From Motley Fool
Does Eli Lilly's Future Depend on its Alzheimer's Drug?
Tickers BIIB LLY RHHBY
Tags RHHBY Market News BIIB
From Motley Fool
Biogen Fails To Convince Benefits Of Alzheimer's Drug To European Regulator
Tickers BIIB
Tags General News Trading Ideas
From Benzinga
If You Invested $100 In Biogen 15 Years Ago, Here's How Much You Would Have Today
Tickers BIIB
Tags Dividends Market News Earnings
From Benzinga
Analyst Ratings for Biogen
Tickers BIIB
Tags Benzinga BIIB BZI/AAR
From Benzinga
Is Biogen Stock a Buy Now?
Tickers BIIB WFC
Tags BIIB Recent Press Releases Market News
From Motley Fool
Down 16% Since October, Could This Stock Make a Turnaround?
Tickers BIIB
Tags Market News Recent Press Releases BIIB
From Motley Fool
Biogen Earnings Conference Call Is Coming Up, Here's What You Need To Know
Tickers BIIB
Tags BIIB Benzinga Earnings
From Benzinga
7 Potential Biotech Stocks Buyout Targets in 2022
Tickers ALNY AMGN AZN BIIB
Tags MRTX ALNY BIIB
From InvestorPlace
Why This Analyst Believes Biogen Is 'Too Good to Ignore'
Tickers BIIB
Tags Market News Mohit Bansal Wells Fargo
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 18, 2022
Tickers AJG APTV AXTA BCRX
Tags REFI RDBX Intraday Update
From Benzinga
3 Biotech Stocks That Could Help Make You a Fortune
Tickers AMGN BIIB MRNA NVAX
Tags MRNA VXRT NVAX
From Motley Fool
Biogen’s Aduhelm Crashes the Biotech Sector
Tickers BIIB NVS VTRS
Tags BIIB Stocks to Sell NASDAQ:BIIB,NASDAQ:VTRS,NYSE:NVS,
From InvestorPlace
Recession Fears are Creating a Golden Opportunity for Biotech Stocks
Tickers AZN BIIB ENTX GLSI
Tags GLSI GME BIIB
From InvestorPlace
Why Is Trevi Therapeutics (TRVI) Stock On the Move Today?
Tickers BIIB CRWD EDU TRVI
Tags EDU CRWD Market News
From InvestorPlace
Why Is Biogen (BIIB) Stock in the Spotlight Today?
Tickers BIIB LLY
Tags Market News NASDAQ:BIIB,NYSE:LLY LLY
From InvestorPlace
Morning Brief: Top Stories Dominating Financial Media on Friday, April 8
Tickers AMZN BA BIIB BRK-A
Tags BRK/A JBLU TSLA
From Benzinga
Layoffs at Bluebird Bio Highlight the Current Struggles of Biotech Picks
Tickers BIIB BLUE GILD IBB
Tags MRK NASDAQ:BLUE,NASDAQ:IBB,NYSEARCA:XBI,NASDAQ:MRNA,,NYSE:NVS,NASDAQ:GILD,NYSE:MRK,NASDAQ:BIIB,NYSE:PFE IBB
From InvestorPlace
Biogen's Alzheimer's Drug Aduhelm Medicare Coverage Restricted To Just Clinical Trials, CMS Finalizes
Tickers BIIB
Tags Aduhelm Biotech Government
From Benzinga
3 Healthcare Stocks That Could Help Set You Up for Life
Tickers BIIB GMED LLY SGEN
Tags Market News Recent Press Releases SGEN
From Motley Fool
Could Amylyx Pharmaceuticals Have a Blockbuster ALS Treatment?
Tickers AMLX BIIB
Tags BIIB Recent Press Releases AMLX
From Motley Fool
Ionis-Biogen Partnered Amyotrophic Lateral Sclerosis Trial Disappoints
Tickers BIIB IONS
Tags Health Care News Trading Ideas
From Benzinga
Is Johnson & Johnson Setting a Dangerous Precedent for the Healthcare Industry?
Tickers BIIB JNJ MRNA OCGN
Tags JNJ Recent Press Releases OCGN
From Motley Fool
Why I Sold Kohl’s Corporation Despite Possible Buyout Deal
Tickers BIIB KSS NLSN
Tags NLSN Market News NYSE:KSS,NYSE:NLSN,NASDAQ:BIIB
From InvestorPlace
Biogen, Eisai Unveil New Data On Another Alzheimer's Candidate, Lecanemab
Tickers BIIB ESALF ESALY
Tags General BIIB Benzinga
From Benzinga
2 Red Flags for Biogen's Future
Tickers BIIB LLY
Tags Market News LLY BIIB
From Motley Fool
Biogen Shares Aduhelm Data In Alzheimer's Disease At 128 Weeks
Tickers BIIB
Tags Phase 3 Trial Market News Biotech
From Benzinga
Biogen, Eisai Amend Their Alzheimer's Drug Marketing Pact
Tickers BIIB ESALF ESALY
Tags ESALF Biotech BIIB
From Benzinga
The Daily Biotech Pulse: Biogen, Eisai Amend Aduhelm Agreement; Anaptys Acne Drug Flunks Midstage Study; Merck, AstraZeneca Discontinue Prostate Cancer Trial
Tickers ALT ANAB ANIP ATHX
Tags GMDA SYRS ANAB
From Benzinga
< Previous 1 2
...
22 23 24 25 26 27 28 29 30
...
32 33 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.